Fig. 2From: The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trialPatients who underwent SNAC and SCR had similar TTP (a) and OS durations (b) to those who underwent SCR directlyBack to article page